$CULL
Cullman Bancorp, Inc. /MD/

2021 Q4 Form 10-K Financial Statement

#000095017022004488 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $13.37M
YoY Change -5.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $120.0K $442.0K
YoY Change 5.49%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.786M
YoY Change -37.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $710.0K $2.094M
YoY Change -53.5%
Income Tax $90.00K $344.0K
% Of Pretax Income 12.68% 16.43%
Net Earnings $620.0K $1.750M
YoY Change -50.65%
Net Earnings / Revenue 13.09%
Basic Earnings Per Share $0.25
Diluted Earnings Per Share $70.86K $0.25
COMMON SHARES
Basic Shares Outstanding 7.406M 6.856M
Diluted Shares Outstanding 6.676M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.213M $3.136M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $9.484M $9.500M $8.576M
YoY Change 10.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $720.0K $1.300M $1.125M
YoY Change -36.0%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $354.7M $354.7M $331.4M
YoY Change 7.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $100.0K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $100.0K $100.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.394M $4.400M $3.958M
YoY Change 11.02%
Total Long-Term Liabilities $4.394M $4.400M $3.958M
YoY Change 11.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $100.0K $100.0K
Total Long-Term Liabilities $4.394M $4.400M $3.958M
Total Liabilities $255.0M $255.0M $274.5M
YoY Change -7.12%
SHAREHOLDERS EQUITY
Retained Earnings $53.27M $49.68M
YoY Change 7.22%
Common Stock $49.75M $6.711M
YoY Change 641.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $99.73M $99.70M $56.88M
YoY Change
Total Liabilities & Shareholders Equity $354.7M $354.7M $331.4M
YoY Change 7.03%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $620.0K $1.750M
YoY Change -50.65%
Depreciation, Depletion And Amortization $120.0K $442.0K
YoY Change 5.49%
Cash From Operating Activities $900.0K $5.106M
YoY Change 48.26%
INVESTING ACTIVITIES
Capital Expenditures -$320.0K $1.305M
YoY Change 203.49%
Acquisitions
YoY Change
Other Investing Activities -$9.730M -$21.36M
YoY Change
Cash From Investing Activities -$10.05M -$22.67M
YoY Change -204.51%
FINANCING ACTIVITIES
Cash Dividend Paid $857.0K
YoY Change 3.13%
Common Stock Issuance & Retirement, Net $37.51M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.63M 19.14M
YoY Change -34.31%
NET CHANGE
Cash From Operating Activities 900.0K 5.106M
Cash From Investing Activities -10.05M -22.67M
Cash From Financing Activities -18.63M 19.14M
Net Change In Cash -27.78M 1.577M
YoY Change -97.09%
FREE CASH FLOW
Cash From Operating Activities $900.0K $5.106M
Capital Expenditures -$320.0K $1.305M
Free Cash Flow $1.220M $3.801M
YoY Change 26.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiability
CY2020 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020 cull Contribution To Foundation
ContributionToFoundation
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020 us-gaap Noncash Contribution Expense
NoncashContributionExpense
CY2021 cull Lease Liabilities Arising From Obtaining Right Of Use Assets
LeaseLiabilitiesArisingFromObtainingRightOfUseAssets
CY2020 cull Proceeds From Merger
ProceedsFromMerger
CY2020 cull Proceeds From Death Benefits
ProceedsFromDeathBenefits
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001845799
CY2021 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
CY2020 cull Gain Loss On Prepayment Of Federal Home Loan Bank Advances
GainLossOnPrepaymentOfFederalHomeLoanBankAdvances
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2021 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
CY2021 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2020 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-40607
CY2021 dei Entity Registrant Name
EntityRegistrantName
Cullman Bancorp, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1990996
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
316 Second Avenue
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
S.W
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Cullman
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
AL
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
35055
CY2021 dei City Area Code
CityAreaCode
256
CY2021 dei Local Phone Number
LocalPhoneNumber
734-1740
CY2021 dei Security12b Title
Security12bTitle
Common stock
CY2021 dei Trading Symbol
TradingSymbol
CULL
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
66900000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7405893
CY2021 dei Auditor Firm
AuditorFirmId
173
CY2021 dei Auditor Name
AuditorName
Crowe LLP
CY2021 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2213000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3136000
CY2021Q4 us-gaap Federal Funds Sold
FederalFundsSold
59725000
CY2020Q4 us-gaap Federal Funds Sold
FederalFundsSold
57225000
CY2021Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
61938000
CY2020Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
60361000
CY2021Q4 cull Available For Sales Securities
AvailableForSalesSecurities
21313000
CY2020Q4 cull Available For Sales Securities
AvailableForSalesSecurities
18875000
CY2021Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0
CY2020Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
173000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2406000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2361000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
252160000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
231799000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9484000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8576000
CY2021Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
400000
CY2020Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
434000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
775000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
1001000
CY2021Q4 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
859000
CY2020Q4 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
2541000
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5737000
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5657000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1323000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
854000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
720000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1125000
CY2021Q4 us-gaap Assets
Assets
354709000
CY2020Q4 us-gaap Assets
Assets
331396000
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
13349000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
14375000
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
218672000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
202588000
CY2021Q4 us-gaap Deposits
Deposits
232021000
CY2020Q4 us-gaap Deposits
Deposits
216963000
CY2021Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
18500000
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
53500000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
60000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
100000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4394000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3958000
CY2021Q4 us-gaap Liabilities
Liabilities
254975000
CY2020Q4 us-gaap Liabilities
Liabilities
274521000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7405893
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6959974
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
74000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
24000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49674000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6687000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53267000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
49679000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
277000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
542000
CY2021Q4 us-gaap Unearned Esop Shares
UnearnedESOPShares
3558000
CY2020Q4 us-gaap Unearned Esop Shares
UnearnedESOPShares
57000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99734000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
56875000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
354709000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
331396000
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2.8409
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
12759000
CY2020 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
13468000
CY2021 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
461000
CY2020 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
530000
CY2021 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
150000
CY2020 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
174000
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
13370000
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
14172000
CY2021 us-gaap Interest Expense Customer Deposits
InterestExpenseCustomerDeposits
1110000
CY2020 us-gaap Interest Expense Customer Deposits
InterestExpenseCustomerDeposits
1696000
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
1171000
CY2021 us-gaap Interest Expense
InterestExpense
1786000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
676000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2020 us-gaap Interest Expense
InterestExpense
2867000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11584000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11305000
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
60000
CY2020 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
152000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
11524000
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
11153000
CY2021 cull Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
846000
CY2020 cull Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
734000
CY2021 us-gaap Premiums Earned Net
PremiumsEarnedNet
152000
CY2020 us-gaap Premiums Earned Net
PremiumsEarnedNet
151000
CY2021 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
260000
CY2020 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
462000
CY2021 cull Gain Loss On Prepayment Of Federal Home Loan Bank Advances
GainLossOnPrepaymentOfFederalHomeLoanBankAdvances
46000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
8000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
2000
CY2021 us-gaap Noninterest Income Other
NoninterestIncomeOther
197000
CY2020 us-gaap Noninterest Income Other
NoninterestIncomeOther
100000
CY2021 us-gaap Noninterest Income
NoninterestIncome
1509000
CY2020 us-gaap Noninterest Income
NoninterestIncome
1449000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6366000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5502000
CY2021 cull Occupancy And Equipment Expenses
OccupancyAndEquipmentExpenses
856000
CY2020 cull Occupancy And Equipment Expenses
OccupancyAndEquipmentExpenses
765000
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
711000
CY2020 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
549000
CY2021 cull Professional And Supervisory Fees
ProfessionalAndSupervisoryFees
549000
CY2020 cull Professional And Supervisory Fees
ProfessionalAndSupervisoryFees
528000
CY2021 cull Office Expense
OfficeExpense
234000
CY2020 cull Office Expense
OfficeExpense
202000
CY2021 cull Advertising Expense Or Refund
AdvertisingExpenseOrRefund
166000
CY2020 cull Advertising Expense Or Refund
AdvertisingExpenseOrRefund
87000
CY2021 cull Federal Deposit Insurance Corporation Expense Rebates
FederalDepositInsuranceCorporationExpenseRebates
79000
CY2020 cull Federal Deposit Insurance Corporation Expense Rebates
FederalDepositInsuranceCorporationExpenseRebates
47000
CY2021 cull Contribution To Foundation
ContributionToFoundation
1581000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
397000
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
419000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
10939000
CY2020 us-gaap Noninterest Expense
NoninterestExpense
8099000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2094000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4503000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
344000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
957000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3546000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3546000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-335000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
630000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-70000
CY2020 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
132000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-265000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
498000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1485000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4044000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
56875000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-265000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
16000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
240000
CY2021 us-gaap Dividends
Dividends
857000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
556000
CY2021 cull Cancelling Of Old Shares And Options Exercised Values
CancellingOfOldSharesAndOptionsExercisedValues
-315000
CY2021 cull Contribution By Mutual Holding Company
ContributionByMutualHoldingCompany
2685000
CY2021 cull Exchange Of Common Stock Values
ExchangeOfCommonStockValues
30000
CY2021 cull Tax Carryforward From Mutual Holding And Prior Holding Company
TaxCarryforwardFromMutualHoldingAndPriorHoldingCompany
64000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1700000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37506000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
99734000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
53395000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3546000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
498000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
54000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
164000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
134000
CY2020 us-gaap Dividends
Dividends
831000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
243000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
56875000
CY2021 us-gaap Profit Loss
ProfitLoss
1750000
CY2020 us-gaap Profit Loss
ProfitLoss
3546000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-60000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-152000
CY2021 us-gaap Noncash Contribution Expense
NoncashContributionExpense
1481000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
473000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
577000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-335000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-98000
CY2021 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
8000
CY2020 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1000
CY2021 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
CY2020 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
CY2021 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
46000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
152000
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
151000
CY2021 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
260000
CY2020 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
462000
CY2021 cull Mortgage Loans Originated For Sale
MortgageLoansOriginatedForSale
8627000
CY2020 cull Mortgage Loans Originated For Sale
MortgageLoansOriginatedForSale
17439000
CY2021 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
9061000
CY2020 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
17728000
CY2021 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
240000
CY2020 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
134000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
556000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
243000
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-226000
CY2020 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
18000
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-40000
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-169000
CY2021 us-gaap Increase Decrease In Other Current Assets And Liabilities Net
IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
-846000
CY2020 us-gaap Increase Decrease In Other Current Assets And Liabilities Net
IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
294000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5106000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3444000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1305000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
430000
CY2021 cull Payment To Acquire Available For Sale Securities
PaymentToAcquireAvailableForSaleSecurities
8868000
CY2020 cull Payment To Acquire Available For Sale Securities
PaymentToAcquireAvailableForSaleSecurities
10701000
CY2021 cull Proceeds From Death Benefits
ProceedsFromDeathBenefits
72000
CY2021 cull Proceeds From Maturities Paydowns And Calls Of Securities
ProceedsFromMaturitiesPaydownsAndCallsOfSecurities
6018000
CY2020 cull Proceeds From Maturities Paydowns And Calls Of Securities
ProceedsFromMaturitiesPaydownsAndCallsOfSecurities
15952000
CY2021 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
116000
CY2020 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
61000
CY2021 cull Payment For Purchase Of Restricted Equity Securities
PaymentForPurchaseOfRestrictedEquitySecurities
-1682000
CY2020 cull Payment For Purchase Of Restricted Equity Securities
PaymentForPurchaseOfRestrictedEquitySecurities
89000
CY2021 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
20381000
CY2020 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
-16894000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22666000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
21687000
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
15058000
CY2020 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
28075000
CY2020 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
48500000
CY2021 cull Repayment Of Federal Home Loan Bank Advances
RepaymentOfFederalHomeLoanBankAdvances
34954000
CY2020 cull Repayment Of Federal Home Loan Bank Advances
RepaymentOfFederalHomeLoanBankAdvances
46500000
CY2021 cull Proceeds From Payments For Stock Options Exercised
ProceedsFromPaymentsForStockOptionsExercised
-16000
CY2020 cull Proceeds From Payments For Stock Options Exercised
ProceedsFromPaymentsForStockOptionsExercised
54000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
857000
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
831000
CY2020 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
164000
CY2021 cull Proceeds From Merger
ProceedsFromMerger
2394000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37512000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19137000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29134000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1577000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
54265000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60361000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6096000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61938000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60361000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1826000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3036000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
651000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
862000
CY2021 cull Transfers For Loans To Foreclosed Assets
TransfersForLoansToForeclosedAssets
80000
CY2020 cull Transfers For Loans To Foreclosed Assets
TransfersForLoansToForeclosedAssets
108000
CY2020 cull Lease Liabilities Arising From Obtaining Right Of Use Assets
LeaseLiabilitiesArisingFromObtainingRightOfUseAssets
223000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: To prepare financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ.</span></p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Concentration of Credit Risk</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: Most of the Company's business activity is with customers located within Cullman County. Therefore, the Company's exposure to credit risk is significantly affected by changes in the economy in the Cullman County area.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20962000
CY2021 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
455000
CY2021 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
104000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21313000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18189000
CY2020 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
702000
CY2020 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
16000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18875000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
4155000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
14580000
CY2021 cull Proceeds From Sales And Calls Of Securities Gross Gain
ProceedsFromSalesAndCallsOfSecuritiesGrossGain
0
CY2020 cull Proceeds From Sales And Calls Of Securities Gross Gain
ProceedsFromSalesAndCallsOfSecuritiesGrossGain
0
CY2021 cull Proceeds From Sales And Calls Of Securities Gross Loss
ProceedsFromSalesAndCallsOfSecuritiesGrossLoss
0
CY2020 cull Proceeds From Sales And Calls Of Securities Gross Loss
ProceedsFromSalesAndCallsOfSecuritiesGrossLoss
0
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
0
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1401000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1451000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
2732000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
2870000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
14070000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
14192000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20962000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21313000
CY2021Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
9261000
CY2020Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
9169000
CY2020Q4 cull Number Of Security Holdings Greater Than Ten Percent Of Equity
NumberOfSecurityHoldingsGreaterThanTenPercentOfEquity
0
CY2021Q4 cull Number Of Security Holdings Greater Than Ten Percent Of Equity
NumberOfSecurityHoldingsGreaterThanTenPercentOfEquity
0
CY2021 us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
0
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
254612000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
234330000
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
46000
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
170000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2406000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2361000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
252160000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
231799000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2361000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
20000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
5000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
60000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2406000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2406000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2406000
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
3440000
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
251172000
CY2021Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
254612000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2218000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
20000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
11000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
152000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2361000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2361000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2361000
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
8191000
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
226139000
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
234330000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
3478000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
3440000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
0
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8220000
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
8191000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
0
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
6693000
CY2021 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
319000
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
5067000
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
316000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
254612000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
234330000
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
104000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
18000
CY2021 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
2878000
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
2336000
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2021 cull Financing Receivable Additional Recorded Investment
FinancingReceivableAdditionalRecordedInvestment
0
CY2020 cull Financing Receivable Additional Recorded Investment
FinancingReceivableAdditionalRecordedInvestment
0
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2021 us-gaap Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
0
CY2020 us-gaap Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
0
CY2021 cull Financing Receivable Troubled Restructured Loans
FinancingReceivableTroubledRestructuredLoans
0
CY2020 cull Financing Receivable Troubled Restructured Loans
FinancingReceivableTroubledRestructuredLoans
0
CY2021 cull Loan Modification Description
LoanModificationDescription
A loan is considered to be in payment default once it is 90 days contractually past due under the modified terms.
CY2021 cull Number Of Deferral Loan
NumberOfDeferralLoan
0
CY2021Q4 cull Internal Risk Rating Of Loan
InternalRiskRatingOfLoan
254612000
CY2020Q4 cull Internal Risk Rating Of Loan
InternalRiskRatingOfLoan
234330000
CY2021Q4 us-gaap Land
Land
1924000
CY2020Q4 us-gaap Land
Land
1365000
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
14208000
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
13624000
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2321000
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2160000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18453000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17149000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8969000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8573000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9484000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8576000
CY2021 us-gaap Depreciation
Depreciation
442000
CY2020 us-gaap Depreciation
Depreciation
419000
CY2021Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000
CY2020Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000
CY2021Q4 us-gaap Time Deposit Liability Above Us Insurance Limit
TimeDepositLiabilityAboveUsInsuranceLimit
34155000
CY2020Q4 us-gaap Time Deposit Liability Above Us Insurance Limit
TimeDepositLiabilityAboveUsInsuranceLimit
35110000
CY2021Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
43787000
CY2021Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
21751000
CY2021Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
5447000
CY2021Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
8199000
CY2021Q4 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
1097000
CY2021Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
18500000
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
53500000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0181
CY2021 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
46500000
CY2021 cull Bank Prepaid Amount
BankPrepaidAmount
35000000
CY2021 cull Recognized Gain Loss
RecognizedGainLoss
46000
CY2021Q4 us-gaap Collateralized Agreements
CollateralizedAgreements
73916000
CY2020Q4 us-gaap Collateralized Agreements
CollateralizedAgreements
89780000
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
55416000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
0
CY2021Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
0
CY2021Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
5000000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
8500000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
0
CY2021Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
5000000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
10000000
CY2021 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
CY2020 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
533000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
811000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
146000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
244000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
679000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1055000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-277000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-82000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-58000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-16000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-335000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-98000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
344000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
957000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
909000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
792000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
550000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
535000
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
342000
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
0
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
47000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
88000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1848000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1415000
CY2021Q4 cull Deferred Tax Liabilities Fhlb Stock Dividends
DeferredTaxLiabilitiesFHLBStockDividends
-55000
CY2020Q4 cull Deferred Tax Liabilities Fhlb Stock Dividends
DeferredTaxLiabilitiesFHLBStockDividends
-55000
CY2021Q4 cull Deferred Tax Liabilities Loan Fees
DeferredTaxLiabilitiesLoanFees
-18000
CY2020Q4 cull Deferred Tax Liabilities Loan Fees
DeferredTaxLiabilitiesLoanFees
-22000
CY2021Q4 cull Deferred Tax Liabilities Basis Difference In Fixed Assets
DeferredTaxLiabilitiesBasisDifferenceInFixedAssets
-354000
CY2020Q4 cull Deferred Tax Liabilities Basis Difference In Fixed Assets
DeferredTaxLiabilitiesBasisDifferenceInFixedAssets
-317000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
74000
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
144000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-24000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-23000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
525000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
561000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1323000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
854000
CY2021 cull Retained Earnings Under Internal Revenue Code
RetainedEarningsUnderInternalRevenueCode
1248000
CY2020 cull Retained Earnings Under Internal Revenue Code
RetainedEarningsUnderInternalRevenueCode
1248000
CY2021 cull Deferred Income Taxes Provided
DeferredIncomeTaxesProvided
0
CY2020 cull Deferred Income Taxes Provided
DeferredIncomeTaxesProvided
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
440000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
946000
CY2021 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
70000
CY2020 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
192000
CY2021 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
54000
CY2020 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
62000
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
112000
CY2020 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
119000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
344000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
957000
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2021 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Company and its subsidiary are subject to U.S. federal income tax as well as income tax of the state of Alabama. The Company is no longer subject to examination by taxing authorities for years before 2018.
CY2021 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2018
CY2021 cull Number Of Deferred Compensation Plan
NumberOfDeferredCompensationPlan
2
CY2021 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
621000
CY2020 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
560000
CY2021Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3389000
CY2020Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
2914000
CY2021 cull Description Of Company Sponsor Deferred Compensation Plan
DescriptionOfCompanySponsorDeferredCompensationPlan
The Company sponsors a profit-sharing plan that covers all employees (salaried and hourly employees who worked 1,000 hours or more) who have one or more years of service. Contributions are 100% vested after three years of service.
CY2021 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
1
CY2021 us-gaap Deferred Compensation Arrangement With Individual Requisite Service Period1
DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
P3Y
CY2021 us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
0.15
CY2021 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
520000
CY2020 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
460000
CY2021 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
208000
CY2020 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
61000
CY2021 cull Employee Stock Ownership Plan Esop Compensation Expense Including Mark To Market Adjustment Amount
EmployeeStockOwnershipPlanEsopCompensationExpenseIncludingMarkToMarketAdjustmentAmount
176000
CY2020 cull Employee Stock Ownership Plan Esop Compensation Expense Including Mark To Market Adjustment Amount
EmployeeStockOwnershipPlanEsopCompensationExpenseIncludingMarkToMarketAdjustmentAmount
134000
CY2021Q4 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
650326
CY2020Q4 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
641708
CY2021Q4 cull Employee Stock Ownership Plan Esop Number Of Unearned Shares
EmployeeStockOwnershipPlanESOPNumberOfUnearnedShares
355829
CY2020Q4 cull Employee Stock Ownership Plan Esop Number Of Unearned Shares
EmployeeStockOwnershipPlanESOPNumberOfUnearnedShares
16057
CY2021Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
1006155
CY2020Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
657765
CY2021Q4 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
4370000
CY2020Q4 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
158000
CY2021 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
2.8409-to-one
CY2021Q4 cull Employee Stock Ownership Plan Esop Deferred Shares Fair Value Per Share
EmployeeStockOwnershipPlanEsopDeferredSharesFairValuePerShare
12.28
CY2020Q4 cull Employee Stock Ownership Plan Esop Deferred Shares Fair Value Per Share
EmployeeStockOwnershipPlanEsopDeferredSharesFairValuePerShare
9.86
CY2020 us-gaap Increase Decrease In Fair Value Of Hedged Item In Price Risk Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInPriceRiskFairValueHedge1
28000
CY2020Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.075
CY2021Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
69739000
CY2021Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1883
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
31476000
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0850
CY2020Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
50690000
CY2020Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1549
CY2020Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
26180000
CY2020Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0800
CY2021Q4 cull Dividends Yet To Be Declare
DividendsYetToBeDeclare
5702000
CY2020Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
4518000
CY2021 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
836000
CY2021 cull Loans And Leases Receivable Related Parties Repayments
LoansAndLeasesReceivableRelatedPartiesRepayments
612000
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
4742000
CY2021Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
3765000
CY2020Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
4384000
CY2021Q4 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
100000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y7M17D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
825000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
68177
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.86
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 cull Impaired Loans Carrying Amount
ImpairedLoansCarryingAmount
104000
CY2020Q4 cull Impaired Loans Carrying Amount
ImpairedLoansCarryingAmount
439000
CY2021Q4 cull Fair Value Of Unpaid Principal Balance
FairValueOfUnpaidPrincipalBalance
141000
CY2020Q4 cull Fair Value Of Unpaid Principal Balance
FairValueOfUnpaidPrincipalBalance
468000
CY2020 cull Impaired Loans Charge Offs
ImpairedLoansChargeOffs
0
CY2021 cull Impaired Loans Charge Offs
ImpairedLoansChargeOffs
0
CY2021 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
37000
CY2020 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
38000
CY2020 cull Impact To Provision For Loan Losses
ImpactToProvisionForLoanLosses
0
CY2021 cull Impact To Provision For Loan Losses
ImpactToProvisionForLoanLosses
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
122290
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.67
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2290
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.30
CY2021 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
220903
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
340903
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.86
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M17D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
340903
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
9.86
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y7M17D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
165000
CY2021Q4 us-gaap Share Price
SharePrice
12.28
CY2021 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2.8409
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
27000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
91000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
4000
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
14000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.50
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0027
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2148
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0123
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
68177
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
387000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y6M29D
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M29D
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3546000
CY2021 us-gaap Distributed Earnings
DistributedEarnings
0
CY2020 us-gaap Distributed Earnings
DistributedEarnings
0
CY2021 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
16000
CY2020 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
41000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1734000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3505000
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7168974
CY2020 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6818352
CY2021 cull Participating Securities
ParticipatingSecurities
131920
CY2020 cull Participating Securities
ParticipatingSecurities
103805
CY2021 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
180771
CY2020 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
31515
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6856283
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6683396
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1734000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3505000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6856283
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6683396
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
109502
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4096
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6676071
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6687492
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2019Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2021Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0167
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
167000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
170000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
55000
CY2021Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P3Y
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
57000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
58000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
59000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
174000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
170000
CY2021 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
133000
CY2020 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
66000
CY2021 cull Lessor Operating Lease Remaining Rental Income Term
LessorOperatingLeaseRemainingRentalIncomeTerm
P5Y
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
119
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
119
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
119
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
113
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
113

Files In Submission

Name View Source Status
0000950170-22-004488-index-headers.html Edgar Link pending
0000950170-22-004488-index.html Edgar Link pending
0000950170-22-004488.txt Edgar Link pending
0000950170-22-004488-xbrl.zip Edgar Link pending
cull-20211231.htm Edgar Link pending
cull-20211231.xsd Edgar Link pending
cull-ex31_1.htm Edgar Link pending
cull-ex31_2.htm Edgar Link pending
cull-ex32.htm Edgar Link pending
cull-ex4_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img228357303_0.jpg Edgar Link pending
img228357303_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
cull-20211231_def.xml Edgar Link unprocessable
cull-20211231_pre.xml Edgar Link unprocessable
cull-20211231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cull-20211231_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cull-20211231_cal.xml Edgar Link unprocessable